Vapotherm (VAPO) Stock Forecast, Price Target & Predictions
VAPO Stock Forecast
Vapotherm stock forecast is as follows: an average price target of $128.00 (represents a 5798.62% upside from VAPO’s last price of $2.17) and a rating consensus of 'Hold', based on 2 wall street analysts offering a 1-year stock forecast.
VAPO Price Target
The average price target for Vapotherm (VAPO) is $128.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $128.00 to $128.00. This represents a potential 5798.62% upside from VAPO's last price of $2.17.
VAPO Analyst Ratings
According to 2 Wall Street analysts, Vapotherm's rating consensus is 'Hold'. The analyst rating breakdown for VAPO stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (50.00%), 1 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).
Vapotherm Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 03, 2022 | Jason Bednar | Piper Sandler | $128.00 | $105.60 | 21.21% | 5798.62% |
The latest Vapotherm stock forecast, released on Oct 03, 2022 by Jason Bednar from Piper Sandler, set a price target of $128.00, which represents a 21.21% increase from the stock price at the time of the forecast ($105.60), and a 5798.62% increase from VAPO last price ($2.17).
Vapotherm Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $2.17 | $2.17 | $2.17 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Vapotherm stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Vapotherm's last price of $2.17. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 03, 2022 | Piper Sandler | Underweight | Underweight | Hold |
| Apr 26, 2022 | Zacks Investment Research | - | Hold | Upgrade |
Vapotherm's last stock rating was published by Piper Sandler on Oct 03, 2022. The company gave VAPO a "Underweight" rating, the same as its previous rate.
Vapotherm Financial Forecast
Vapotherm Revenue Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | $15.17M | $17.73M | $18.66M | $21.62M | $32.31M | $19.11M | $12.30M |
| Avg Forecast | $17.41M | $16.88M | $20.90M | $19.92M | $16.29M | $23.78M | $19.91M | $21.62M | $35.25M | $16.22M | $12.62M |
| High Forecast | $17.41M | $16.88M | $20.90M | $20.10M | $16.98M | $28.54M | $23.89M | $25.95M | $42.29M | $19.46M | $15.15M |
| Low Forecast | $17.41M | $16.88M | $20.90M | $19.73M | $15.60M | $19.03M | $15.93M | $17.30M | $28.20M | $12.98M | $10.10M |
| # Analysts | 1 | 1 | 1 | 1 | 2 | 13 | 16 | 11 | 15 | 11 | 9 |
| Surprise % | - | - | - | - | 0.93% | 0.75% | 0.94% | 1.00% | 0.92% | 1.18% | 0.97% |
Vapotherm's average Quarter revenue forecast for Dec 23 based on 1 analysts is $19.92M, with a low forecast of $19.73M, and a high forecast of $20.10M. VAPO's average Quarter revenue forecast represents a 31.32% increase compared to the company's last Quarter revenue of $15.17M (Sep 23).
Vapotherm EBITDA Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 13 | 16 | 11 | 15 | 11 | 9 |
| EBITDA | - | - | - | - | $-10.27M | $-13.62M | $-15.93M | $-18.52M | $-8.10M | $-11.48M | $-11.31M |
| Avg Forecast | $-10.96M | $-10.63M | $-16.35M | $-12.54M | $-10.25M | $-14.87M | $-18.59M | $-13.52M | $-8.91M | $-9.41M | $-11.61M |
| High Forecast | $-10.96M | $-10.63M | $-13.08M | $-12.42M | $-9.82M | $-11.89M | $-14.87M | $-10.81M | $-7.13M | $-7.53M | $-9.29M |
| Low Forecast | $-10.96M | $-10.63M | $-19.62M | $-12.65M | $-10.69M | $-17.84M | $-22.31M | $-16.22M | $-10.69M | $-11.29M | $-13.93M |
| Surprise % | - | - | - | - | 1.00% | 0.92% | 0.86% | 1.37% | 0.91% | 1.22% | 0.97% |
undefined analysts predict VAPO's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Vapotherm's previous annual EBITDA (undefined) of $NaN.
Vapotherm Net Income Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 13 | 16 | 11 | 15 | 11 | 9 |
| Net Income | - | - | - | - | $-15.13M | $-18.09M | $-21.44M | $-22.94M | $-10.48M | $-13.82M | $-12.97M |
| Avg Forecast | $9.93M | $8.65M | $-17.78M | $-10.50M | $-13.92M | $-16.16M | $-20.87M | $-14.69M | $-11.35M | $-11.37M | $-13.30M |
| High Forecast | $9.93M | $8.65M | $-14.22M | $-10.50M | $-13.92M | $-12.93M | $-16.70M | $-11.76M | $-9.08M | $-9.10M | $-10.64M |
| Low Forecast | $9.93M | $8.65M | $-21.34M | $-10.50M | $-14.43M | $-19.40M | $-25.04M | $-17.63M | $-13.62M | $-13.65M | $-15.96M |
| Surprise % | - | - | - | - | 1.09% | 1.12% | 1.03% | 1.56% | 0.92% | 1.22% | 0.98% |
Vapotherm's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. VAPO's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Vapotherm SG&A Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 13 | 16 | 11 | 15 | 11 | 9 |
| SG&A | - | - | - | - | $12.40M | $15.36M | $16.52M | $22.28M | $21.96M | $18.57M | $14.04M |
| Avg Forecast | $15.82M | $15.34M | $17.27M | $18.10M | $14.80M | $15.70M | $18.09M | $14.27M | $23.96M | $15.25M | $11.47M |
| High Forecast | $15.82M | $15.34M | $20.72M | $18.26M | $15.43M | $18.84M | $21.71M | $17.12M | $28.75M | $18.30M | $13.76M |
| Low Forecast | $15.82M | $15.34M | $13.81M | $17.93M | $14.17M | $12.56M | $14.47M | $11.42M | $19.16M | $12.20M | $9.18M |
| Surprise % | - | - | - | - | 0.84% | 0.98% | 0.91% | 1.56% | 0.92% | 1.22% | 1.22% |
Vapotherm's average Quarter SG&A projection for Dec 23 is $18.10M, based on 1 Wall Street analysts, with a range of $17.93M to $18.26M. The forecast indicates a 45.98% rise compared to VAPO last annual SG&A of $12.40M (Sep 23).
Vapotherm EPS Forecast
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 13 | 16 | 11 | 15 | 11 | 9 |
| EPS | - | - | - | - | $-0.00 | $-0.45 | $-0.78 | $-0.87 | $-0.41 | $-0.66 | $-0.77 |
| Avg Forecast | $1.54 | $1.34 | $-1.60 | $-1.63 | $-2.16 | $1.43 | $1.95 | $1.43 | $-0.48 | $-0.46 | $-0.80 |
| High Forecast | $1.54 | $1.34 | $-1.60 | $-1.63 | $-2.16 | $1.43 | $1.95 | $1.43 | $-0.38 | $-0.37 | $-0.64 |
| Low Forecast | $1.54 | $1.34 | $-1.60 | $-1.63 | $-2.24 | $1.43 | $1.95 | $1.43 | $-0.58 | $-0.55 | $-0.96 |
| Surprise % | - | - | - | - | 0.00% | -0.31% | -0.40% | -0.61% | 0.85% | 1.43% | 0.96% |
According to undefined Wall Street analysts, Vapotherm's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to VAPO previous annual EPS of $NaN (undefined).
Vapotherm Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BJDX | Bluejay Diagnostics | $0.07 | $10.00 | 14185.71% | Buy |
| VAPO | Vapotherm | $2.17 | $128.00 | 5798.62% | Hold |
| RPID | Rapid Micro Biosystems | $1.08 | $8.00 | 640.74% | Hold |
| SGHT | Sight Sciences | $4.66 | $10.25 | 119.96% | Hold |
| NPCE | NeuroPace | $6.37 | $12.88 | 102.20% | Buy |
| HSCS | Heart Test Laboratories | $2.73 | $3.00 | 9.89% | Buy |
VAPO Forecast FAQ
Is Vapotherm a good buy?
No, according to 2 Wall Street analysts, Vapotherm (VAPO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of VAPO's total ratings.
What is VAPO's price target?
Vapotherm (VAPO) average price target is $128 with a range of $128 to $128, implying a 5798.62% from its last price of $2.17. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Vapotherm stock go up soon?
According to Wall Street analysts' prediction for VAPO stock, the company can go up by 5798.62% (from the last price of $2.17 to the average price target of $128), up by 5798.62% based on the highest stock price target, and up by 5798.62% based on the lowest stock price target.
Can Vapotherm stock reach $3?
VAPO's average twelve months analyst stock price target of $128 supports the claim that Vapotherm can reach $3 in the near future.
What are Vapotherm's analysts' financial forecasts?
VAPO's analysts financial forecasts for the fiscal year (Dec 2023) are as follows: average revenue is $59.99M (high $65.62M, low $54.36M), average EBITDA is $-37.66M (high $-34.137M, low $-41.183M), average net income is $-40.582M (high $-37.349M, low $-44.33M), average SG&A $48.6M (high $52.53M, low $44.66M), and average EPS is $-2.361 (high $-2.361, low $-2.441).
Did the VAPO's actual financial results beat the analysts' financial forecasts?
Based on Vapotherm's last annual report (Dec 2022), the company's revenue was $66.8M, beating the average analysts forecast of $41.53M by 60.84%. Apple's EBITDA was $-72.127M, beating the average prediction of $-32.107M by 124.64%. The company's net income was $-113M, beating the average estimation of $-35.564M by 218.46%. Apple's SG&A was $73.89M, beating the average forecast of $32.36M by 128.31%. Lastly, the company's EPS was $-4.24, missing the average prediction of $3.38 by -225.35%. In terms of the last quarterly report (Sep 2023), Vapotherm's revenue was $15.17M, missing the average analysts' forecast of $16.29M by -6.89%. The company's EBITDA was $-10.271M, beating the average prediction of $-10.255M by 0.16%. Vapotherm's net income was $-15.13M, beating the average estimation of $-13.916M by 8.72%. The company's SG&A was $12.4M, missing the average forecast of $14.8M by -16.25%. Lastly, the company's EPS was $-0.0024, missing the average prediction of $-2.16 by -99.89%